Clinical Intelligence
The case for prevention
The case for preventive medicine is no longer emerging — it is established. Across clinical domains, earlier detection, proactive risk management and lifestyle optimisation consistently produce better outcomes and longer functional healthspans than reactive treatment.
Cardiovascular disease prevention
The evidence for prevention is among the strongest in medicine. Modifying lipids, blood pressure, glucose and smoking can reduce cardiovascular event risk by 30–60%. Advanced markers such as Lp(a) and coronary artery calcium identify risk that standard testing misses — so our Annual Health Assessment measures them.
Cancer early detection
Outcomes are largely determined by the timing of detection. Five-year survival for stage I colorectal cancer exceeds 90%, against under 15% at stage IV. A screening programme guided by your Health Director and integrated with your Health Passport keeps screening timely and complete — nothing falls through the gap because a family moved or changed clinics.
Cognitive health
Multimodal lifestyle intervention can slow cognitive decline in at-risk individuals — but the window opens years or decades before symptoms appear. Tracking cognitive function from the start of membership is designed to catch change at the earliest, most treatable moment.
The longevity paradigm
Longevity medicine sits at the intersection of preventive medicine and biological ageing science. Our approach is evidence-first: we incorporate well-established interventions and track their outcomes, and we do not endorse speculative treatments without an adequate evidence base.
Research Access
Personalised to your family
Molliora Intelligence turns this evidence base into specific, personal guidance for your family, synthesised with your health history and delivered through your Health Director.
Request Membership